GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Kanghua Biological Products Co Ltd (SZSE:300841) » Definitions » Research & Development

Chengdu Kanghua Biological Products Co (SZSE:300841) Research & Development : ¥160 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Kanghua Biological Products Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Chengdu Kanghua Biological Products Co's Research & Development for the three months ended in Sep. 2024 was ¥28 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ¥160 Mil.


Chengdu Kanghua Biological Products Co Research & Development Historical Data

The historical data trend for Chengdu Kanghua Biological Products Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Kanghua Biological Products Co Research & Development Chart

Chengdu Kanghua Biological Products Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 22.79 58.25 78.88 179.94 253.03

Chengdu Kanghua Biological Products Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.11 67.10 25.83 38.70 27.88

Chengdu Kanghua Biological Products Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥160 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengdu Kanghua Biological Products Co  (SZSE:300841) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Chengdu Kanghua Biological Products Co Research & Development Related Terms

Thank you for viewing the detailed overview of Chengdu Kanghua Biological Products Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Kanghua Biological Products Co Business Description

Traded in Other Exchanges
N/A
Address
No. 182, Beijing Road, Chengdu Economic and Technological Development Zone, Sichuan Province, Chengdu, CHN, 610100
Chengdu Kanghua Biological Products Co Ltd is engaged in research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine (human diploid cell) for Human Use, freeze-dried - HDCV. The company's products include ACYW135 Meningococcal Polysaccharide Vaccine; and Rabies Vaccine.
Executives
Sun Wan Feng Executives
Hou Wen Li Directors, executives
Wu Wen Nian Executives
Chen Huai Gong Executives
Li Sheng You Executives
Wang Qing Han Directors, executives
Li Xiao Wen Supervisors

Chengdu Kanghua Biological Products Co Headlines

No Headlines